New York Drugmaker Cited for Multitude of Violations

Drug Industry Daily
A A
Kingston Pharma’s Masena, New York facility netted a lengthy Form 483 from the FDA for serious quality violations.

To View This Article:

Login

Subscribe To Drug Industry Daily